Being careful would be my guess as to their intentions. I think Darren Smith is acting like a man completely overtaken by events. GW gave him a team with a lack of governance, risk and compliance and so forth so this type of thing is to be expected. They have difficulty understanding the rules, when they get a legal report, they keep it confidential, the governance is all-at-sea.
It has nothing to do with the science and the growth of the company, a bit of a distraction and Smith should get back to running a biopharma company IMHO but pls DYOR with excellent potential in treating liver cancer.
Ann: Foreshadowed Federal Court of Australia Proceeding, page-47
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $76.70M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.0¢ | 17.5¢ | $6.597K | 37.58K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 5847101 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 237659 | 23 |
View Market Depth
| Last trade - 14.58pm 27/09/2024 (20 minute delay) ? |
| SRX (ASX) Chart |